| Element List | Current Quarter | Similar quarter for previous year | %Change | Previous Quarter | % Change |
|---|---|---|---|---|---|
| Sales/Revenue | 193.84 | 190.14 | 1.945 | 117.46 | 65.026 |
| Gross Profit (Loss) | 74.86 | 71.66 | 4.465 | 42.98 | 74.174 |
| Operational Profit (Loss) | 57.39 | 52.24 | 9.858 | 21.85 | 162.654 |
| Net Profit (Loss) after Zakat and Tax | 52.32 | 48.34 | 8.233 | 17.51 | 198.8 |
| Total Comprehensive Income | 52.04 | 48.1 | 8.191 | 17.56 | 196.355 |
| All figures are in (Millions) Saudi Arabia, Riyals | |||||
| Element List | Current Period | Similar period for previous year | %Change |
|---|---|---|---|
| Sales/Revenue | 311.29 | 291.32 | 6.855 |
| Gross Profit (Loss) | 117.84 | 111.57 | 5.619 |
| Operational Profit (Loss) | 79.23 | 72.07 | 9.934 |
| Net Profit (Loss) after Zakat and Tax | 69.84 | 64.54 | 8.211 |
| Total Comprehensive Income | 69.6 | 64.49 | 7.923 |
| Total Share Holders Equity (after Deducting Minority Equity) | 560.64 | 528.53 | 6.075 |
| Profit (Loss) per Share | 2.33 | 2.15 | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
| Element List | Explanation |
|---|---|
| Increase (Decrease) in Net Profit for Current Quarter Compared to the Same Quarter of the Previous Year is Attributed to | The increase in the net income attributable to the shareholders of the company for the second quarter of 2020, compared to the same quarter of the previous year, is mainly due to: |
Growth of 1.95% in sales, as a result of the entry of new products, and the signing of a contract for the supplying of medical supplies. In addition, company efforts to improve the management of expenditures and to better restrain the controllable costs, and taking advantage of government initiatives to mitigate the effects of the COVID-19.
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.